Howard Liang
2017
In 2017, Howard Liang earned a total compensation of $3.6M as Chief Financial Officer and Chief Strategy Officer at BeiGene, Ltd., a 8% decrease compared to previous year.
Compensation breakdown
| Bonus | $218,400 |
|---|---|
| Option Awards | $3,017,750 |
| Salary | $380,000 |
| Other | $8,100 |
| Total | $3,624,251 |
Liang received $3M in option awards, accounting for 83% of the total pay in 2017.
Liang also received $218.4K in bonus, $380K in salary and $8.1K in other compensation.
Rankings
In 2017, Howard Liang's compensation ranked 2,901st out of 14,666 executives tracked by ExecPay. In other words, Liang earned more than 80.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,901 out of 14,666 | 80th |
Division Manufacturing | 1,000 out of 5,770 | 83rd |
Major group Chemicals And Allied Products | 266 out of 2,074 | 87th |
Industry group Drugs | 203 out of 1,730 | 88th |
Industry Pharmaceutical Preparations | 161 out of 1,329 | 88th |
Source: SEC filing on April 30, 2018.
Liang's colleagues
We found five more compensation records of executives who worked with Howard Liang at BeiGene, Ltd. in 2017.
2017
John Oyler
BeiGene, Ltd.
Chief Executive Officer
2017
Amy Peterson
BeiGene, Ltd.
Chief Medical Officer
2017
Hematology Peterson
BeiGene, Ltd.
Chief Medical Officer
2017
Jane Huang
BeiGene, Ltd.
Chief Medical Officer
2017
Hematology Li
BeiGene, Ltd.